article thumbnail

Pharmaceutical Marketing in 2025: Trends, Tech, and Targeting That Matter Most

Pharma Marketing Network

Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. In 2025, success is tied to delivering a consistent experience across digital and offline interactions. Disclaimer “This content is not medical advice.

HIPAA 52
article thumbnail

Amgen’s Soliris biosimilar clears phase 3, but won’t launch until 2025

pharmaphorum

The biotech has confirmed it will not launch the biosimilar until March 2025 however, honouring the terms of its 2020 agreement with Alexion that resolved litigation over the validity of patents covering Soliris (eculizumab) in the US.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

No ACNU Yet; Effective Date Delayed Again

The FDA Law Blog

Livornese On Friday, March 21, 2025, FDA announced that it was further delaying the effective date for the ACNU final rule until May 27, 2025. Originally, the Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) final rule was to become effective January 27, 2025. By Deborah L.

FDA 59
article thumbnail

Antibiotic Minimum Inhibitory Concentrations: Do You know These 6 Things About Them?

IDStewardship

coli labeled as susceptible in 2010 may be labeled as resistant in 2025. MIC breakpoints can change over time CLSI and other similar bodies change breakpoints periodically based on epidemiological data and other emerging information. This means that the same E. CLSI releases updates on which breakpoints are changing and why.

Labelling 130
article thumbnail

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

Pharmafile

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product (..)

article thumbnail

STAT+: Akili abandons prescription business model, to lay off 40% of workers

STAT

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues.

Labelling 131
article thumbnail

Guidance for medicine packaging under Windsor Framework

European Pharmaceutical Review

The agreement stipulates that certain conditions must be met in the labelling and packaging of these medicinal products. The following new measures are set to be introduced on 1 January 2025. After this date: Under the framework, medicines can have the same packaging and labelling across the UK.

Packaging 105